Figure 1 Discussion
Waardenburg syndrome (WS) is named after a Dutch ophthalmologist, who first described a patient with hearing loss, dystopia canthorum (i.e. lateral displacement of inner canthi of eyes) and retinal pigmentary changes in 1947. Since then 4 types have been described. 5 .
Evidence exists that the MITF gene (microphthalmiaassociated transcription factor) transactivates the Tyrosine gene, which is involoved in melanocyte differentiation 6 . A study in Watanabe in 1998 showed that PAX3 transactivates MITF-promotor. Mutations in the PAX3 gene, therefore, could affect regulation of the melanocyte differentiation. SOX10 gene interacts with PAX3 in regulating MITF gene and mutations of this gene have been implicated in the pathogenesis of WS4 7 .
The 4 types are differentiated as follows: 3, 8 • Type 1: hearing loss, dystopia canthorum and pigmentary abnormalities of the hair, skin and eyes.
• Type 2: all features of WS1 except dystopia canthorum.
• Type 3: features of type 1 & severe contractures (Klein-Waardenburg syndrome).
• Type 4: WS with associated Hircshprung disease (Waardenburg-Shah syndrome).
The following criteria have been proposed by the Waardenburg syndrome consortium to aid the diagnosis 7 . The presence of 2 major or 1 major plus 2 minor criteria are considered to be diagnostic of WS.
Major criteria
Congenital sensory neural hearing loss Pigmentary disturbances of the iris Hair hypopigmentation Affected 1 st degree relative Dystopia canthorum
Minor criteria
Congenital leucoderma Synophrys or medial eye brow flare Broad, high nasal root Hypoplasia of alae nasi Premature graying of hair As our patient has pigmentary disturbances of the eyes in the presence of dystopia canthorum with an obvious family history, Waardenburg syndrome type 1 is most likely.
For confirmation of the diagnosis molecular testing in the form of mutation analysis of the PAX3 gene is available. Management issues would be genetic counseling and attending to the hearing impairment with a cochlear implant which is the only remedy. Prognostically, the affected are of normal cognition and their functions would depend on early detection of the hearing defect and initiation of stimulation. Mortality rates are comparable with the normal population.
